Maki Imakura is a Registered USPTO Patent Attorney who is excited to work with entrepreneurs and business working on cutting-edge technology. She received a B.S. in Cellular & Molecular Biology with a minor in Chemistry from the University of Washington. Maki received her J.D. from the Seattle University School of Law. Maki draws on her technical background in life sciences research and experiences with drug discovery involving large data sets and collaboration to provide a unique perspective for clients on their technology and intellectual property needs.
During her scientific career, Maki worked in the fields of cancer research and drug discovery. Maki conducted research in labs at the University of Washington, the Fred Hutchinson Cancer Research Institute, and Rosetta Inpharmatics, a wholly owned subsidiary of Merck & Co., Inc. She worked on analyzing mutants of the HIV-1 vpr gene for the gene’s involvement in nuclear import and export. Maki’s industry experience focused on the area of oncology and developing expertise in automation and high-throughput techniques, leading to developing and running Merck’s first genome-scale siRNA screen.
Maki has experience conducting patentability searches, freedom to operate analyses, and infringement risk analyses. She has drafted patent applications for computer software and hardware methods and various devices. In addition, Maki has also managed patent portfolio activities by outside counsel and assisted with drafting opinion letters.
Maki is admitted to practice in Washington State, and the U.S. District Court for the Western District of Washington. Maki is also registered to practice before the U.S. Patent and Trademark Office.
REGISTRATION & LICENSE
- Washington State Bar Association # 44924
- United States Patent and Trademark Office: Reg. # 68118
- U.S. District Court for the Western District of Washington State
- Rosetta Inpharmatics, a wholly-owned subsidiary of Merck & Co.
- Fred Hucthinson Cancer Research Institute
- Juris Doctor (J.D.) from Seattle University School of Law
- Bachelor of Science in Cell and Molecular Biology earned from University of Washington
- FindLaw Profile
- Avvo Profile
- Functional Genomics Identifies Therapeutic Targets for MYC-Driven Cancer
- MicroRNA miR-210 Modulates Cellular Response to Hypoxia Through the MYC Antagonist MNT
- Small Interfering RNA Screens Reveal Enhanced Cisplatin Cytotoxicity in Tumor Cells Having both BRCA Network and TP53 Disruptions